CFAR3 Travel Grant winners attend AAAAI Annual Meeting in Washington DC

Published

Monday, February 26, 2024 - 9:00 AM

Dr Tim Brettig and Kayla Parker, were the first CFAR3 Travel Grant recipients to present their work on the world stage. The pair shared their research into peanut allergy diagnostics and costs; and childhood natural resolution rates at the American Academy of Allergy Asthma & Immunology (AAAAI) Annual Meeting this week.

Allergic disease experts converged on Washington DC from 23 - 26 February to discuss the latest cutting-edge allergy research and collaborate with colleagues from around the world.

Dr Tim Brettig

CFAR PhD Scholar and NACE Postdoc Fellow

• Oral presentation
• A diagnostic algorithm using peanut SPT and Ara h 2 sIgE reduces number of OFCs and cost of peanut allergy diagnosis in a clinical setting: a cost comparison analysis. Learn more

Kayler Parker

PhD candidate supervised by Professor Kirsten Perrett, CFAR Director

• Poster presentation
• Longitudinal peanut and Ara h 2 specific-IgE, -IgG4 and -IgG4/-IgE ratios are associated with the natural resolution of peanut allergy in childhood. Learn more

Other round 1 CFAR3 Travel Grant recipients are:

• Dr Sarah Ashley (EAACI 2024) presenting on Allergen specific IgE is a stronger predictor of remission following Peanut Oral Immunotherapy in children aged 1-10 years
• Dr Nur Sabrina Idrose (ISEE-AWPC and ISES-AC joint conference 2024) presenting on aeroallergen exposure: Determinants, climate change influences and health implications
• Dr Victoria Soriano (World Congress of Epidemiology 2024) presenting on prevalence of food allergy remains high after changes in infant feeling policy in Australia.